Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 866209

Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients

Batinić, Josip; Perić, Zinaida; Šegulja, Dragana; Last, James; Perković, Sanja; Dubravčić, Klara; Volarić, Lidija; Sertić, Dubravka; Radman, Ivo; Bašić-Kinda Sandra et al.
Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients // 56th ASH Annual Meeting Abstracts, Blood 124, 21
Washington (MD): American Society of Hematology (ASH), 2014. 2050, 1 (poster, međunarodna recenzija, prošireni sažetak, znanstveni)

CROSBI ID: 866209 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients

Autori
Batinić, Josip ; Perić, Zinaida ; Šegulja, Dragana ; Last, James ; Perković, Sanja ; Dubravčić, Klara ; Volarić, Lidija ; Sertić, Dubravka ; Radman, Ivo ; Bašić-Kinda Sandra ; Matišić, Danica ; Batinić, Drago ; Labar, Boris ; Nemet, Damir

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, znanstveni

Izvornik
56th ASH Annual Meeting Abstracts, Blood 124, 21 / - Washington (MD) : American Society of Hematology (ASH), 2014

Skup
56th ASH Annual Meeting Abstracts

Mjesto i datum
San Francisco (CA), Sjedinjene Američke Države, 06.12.2014. - 10.12.2014

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
multiple myeloma ; immunoglobulin, heavy/light chains, immunoassay

Sažetak
Evaluation of the clinical utility of the novel heavy/light chain immunoassay for the assessment of multiple myeloma patients.The novel heavy/light chain allows accurate measurement of monoclonal immunoglobulins and can be more sensitive than standard techniques at detecting residual disease. Abnormal heavy/light chain ratios and immunoglobulin isotype pair suppression may have prognostic significance for multiple myeloma patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Klinički bolnički centar Zagreb

Profili:

Avatar Url Dubravka Sertić (autor)

Avatar Url Drago Batinić (autor)

Avatar Url Boris Labar (autor)

Avatar Url JOSIP BATINIĆ (autor)

Avatar Url Danica Matišić (autor)

Avatar Url Dragana Šegulja (autor)

Avatar Url Zinaida Perić (autor)

Avatar Url Damir Nemet (autor)

Avatar Url KLARA DUBRAVČIĆ (autor)

www.bloodjournal.org

Citiraj ovu publikaciju:

Batinić, Josip; Perić, Zinaida; Šegulja, Dragana; Last, James; Perković, Sanja; Dubravčić, Klara; Volarić, Lidija; Sertić, Dubravka; Radman, Ivo; Bašić-Kinda Sandra et al.
Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients // 56th ASH Annual Meeting Abstracts, Blood 124, 21
Washington (MD): American Society of Hematology (ASH), 2014. 2050, 1 (poster, međunarodna recenzija, prošireni sažetak, znanstveni)
Batinić, J., Perić, Z., Šegulja, D., Last, J., Perković, S., Dubravčić, K., Volarić, L., Sertić, D., Radman, I. & Bašić-Kinda Sandra et al. (2014) Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients. U: 56th ASH Annual Meeting Abstracts, Blood 124, 21.
@article{article, author = {Batini\'{c}, Josip and Peri\'{c}, Zinaida and \v{S}egulja, Dragana and Last, James and Perkovi\'{c}, Sanja and Dubrav\v{c}i\'{c}, Klara and Volari\'{c}, Lidija and Serti\'{c}, Dubravka and Radman, Ivo and Mati\v{s}i\'{c}, Danica and Batini\'{c}, Drago and Labar, Boris and Nemet, Damir}, year = {2014}, pages = {1}, chapter = {2050}, keywords = {multiple myeloma, immunoglobulin, heavy/light chains, immunoassay}, title = {Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients}, keyword = {multiple myeloma, immunoglobulin, heavy/light chains, immunoassay}, publisher = {American Society of Hematology (ASH)}, publisherplace = {San Francisco (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave}, chapternumber = {2050} }
@article{article, author = {Batini\'{c}, Josip and Peri\'{c}, Zinaida and \v{S}egulja, Dragana and Last, James and Perkovi\'{c}, Sanja and Dubrav\v{c}i\'{c}, Klara and Volari\'{c}, Lidija and Serti\'{c}, Dubravka and Radman, Ivo and Mati\v{s}i\'{c}, Danica and Batini\'{c}, Drago and Labar, Boris and Nemet, Damir}, year = {2014}, pages = {1}, chapter = {2050}, keywords = {multiple myeloma, immunoglobulin, heavy/light chains, immunoassay}, title = {Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients}, keyword = {multiple myeloma, immunoglobulin, heavy/light chains, immunoassay}, publisher = {American Society of Hematology (ASH)}, publisherplace = {San Francisco (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave}, chapternumber = {2050} }

Časopis indeksira:


  • Scopus
  • MEDLINE

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.